Sustained Benefits With Mepolizumab in Severe Eosinophilic Asthma
A fifth of patients no longer needed oral steroids 2 years after starting biologic by Salynn Boyles SAN ANTONIO — Treatment with the interleukin-5 (IL-5) antagonist mepolizumab (Nucala) increased freedom from…